Dr Muki Shey
Affiliations
- Associate Member, Institute of Infectious Disease and Molecular Medicine
- Chief Research Officer and Wellcome Intermediate Fellow, Department of Medicine, Faculty of Health Sciences
- Contributing investigator, Wellcome Centre for Infectious Disease Research in Africa (CIDRI-Africa)
Key Expertise
Biomarker Discovery, Bacterial Infections, Covid-19, HIV, TB
Main Research Focus
Muki Shey's main research interest is investigating the immunology and the intersection with genetics (Immunogenetics) of infectious diseases, and the mechanisms of resistance to Mycobacterium Tuberculosis (M. tb) infection (and TB disease) in highly exposed healthcare workers. Muki is also interested in Biomarkers including protein and gene signatures that define resistance to infection with M.tb.
Other research interests include studying how HIV and other viral diseases, including COVID-19, affect immune responses to M.tb infection.
He also has interest in determinants of vaccine uptake or hesitancy to COVID-19, Influenza and HPV vaccines.
Most Significant Paper Authored in 2025
Bhengu, P., Wiysonge, C. S., Katoto, P. D. M. C., Ndwandwe, D., Cooper, S., Bhengu, S., Mazingisa, A. V., Saber, T., Sithole, M., Smith, D., Tembe, L. G., Kuodi, P., & Shey, M. S. (2025)
HPV vaccination is crucial for preventing HPV-related cancers, yet uptake remains low due to various barriers, particularly among adolescents.. We evaluated behavioural and social drivers of low uptake of the school-based HPV vaccination among young and adolescent girls in EThekwini District of KwaZulu-Natal province of South Africa. Awareness of the HPV program, confidence in vaccine safety, and endorsement by religious leaders were significant predictors of acceptance. Despite high acceptance (93.5%) and confidence in safety (93.7%), actual vaccination rates were lower, with only 42.9% reporting vaccination. This gap reflects the "intention–behaviour gap," where positive attitudes do not translate into action.